MALT lymphoma laboratory tests

Revision as of 20:30, 24 August 2015 by Jyostna Chouturi (talk | contribs)
Jump to navigation Jump to search

MALT lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating MALT Lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Upper GI Endoscopy

CT

MRI

Endoscopic Ultrasound

Biopsy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

MALT lymphoma laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of MALT lymphoma laboratory tests

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onMALT lymphoma laboratory tests

CDC on MALT lymphoma laboratory tests

MALT lymphoma laboratory tests in the news

on MALT lymphoma laboratory tests

Directions to Hospitals Treating MALT lymphoma

Risk calculators and risk factors for MALT lymphoma laboratory tests

{{CMG]]

Overview

Laboratory Findings

The initial diagnosis is made by biopsy of suspicious lesions on esophagogastroduodenoscopy (EGD, upper endoscopy). Simultaeneously tests for H pylori are also done to detect the presence of this microbe.

References

Template:WH Template:WS